Commercialisation news

The latest commercialisation news from the University of Sheffield.

Off
Three people networking at the Innovation Sprint event

The Northern Triangle Talent Project: One year on

The Northern Triangle Talent (NTT) project, a collaboration between Sheffield, Leeds, and Manchester universities, is powering northern spinouts by building a strong, globally-focused mentor community.
Doctor audiologist using otoscope while examining ear of his senior adult patient in doctor's office

First-in-human trial for regenerative cell therapy for sensorineural hearing loss approved 

Rinri Therapeutics, a world leading spinout company from the University of Sheffield dedicated to transforming sensorineural hearing loss (SNHL) with regenerative cell therapy, has received approval to begin its first-in-human clinical trial. 
Brain-inspired neuromorphic computing

AI-driven spinout set to transform advanced manufacturing

Yorkshire AI Labs, in partnership with Dr Rob Ward and the University of Sheffield’s Advanced Manufacturing Research Centre (AMRC), has launched DigitalCNC, an AI-driven precision manufacturing software company.
Sheffield city centre at night time

University Spinouts: The Sheffield Difference

Sheffield is creating a strong future for University spinouts. With our growing investor network, improving infrastructure and rich talent pool, we are laying the foundations for the next generation of research-driven innovators to thrive.
Electric signals

Crucible Therapeutics awarded £2.3 million to develop breakthrough therapies that address underlying causes of MND

Crucible Therapeutics, a biotechnology spinout company, and University of Sheffield secure a £2.3 million Innovate UK Biomedical Catalyst award to develop breakthrough siRNA therapies that address underlying causes of Motor Neuron Disease (MND).
Geoptic logo

Geoptic awarded prestigious King’s Award for Enterprise in Innovation

Geoptic has been awarded a King’s Award for Enterprise in the Innovation category — considered the highest official honours for UK businesses.

DNA strand

FDA approves trial to advance pioneering treatment for Hereditary Spastic Paraplegia (HSP)

The US Food and Drug Administation (FDA) has approved BlackfinBio Limited’s Phase 1/2 clinical trial for its novel adeno-associated virus (AAV) gene therapy targeting Hereditary Spastic Paraplegia (HSP) Type 47 (SPG47).
Researcher working in AMRC facility

Leading investors back Northern Gritstone with new £50 million fundraise

Northern Gritstone has announced its latest fundraise of £50 million from leading institutional investors bringing its total permanent capital to £362 million.

DNA strands

Sheffield spinout takes major step towards advancing pioneering treatments for Hereditary Spastic Paraplegia (HSP)

BlackfinBio Limited is a spinout company from the University of Sheffield set to pioneer novel therapies for rare genetic neurological diseases.

Exciting Instruments team

University of Sheffield spinout secures £4m in seed funding round - technology set to support health-related research

A University of Sheffield spinout that has developed a single-molecule detection platform to support health research has raised £4m in funding.
Laboratory technician uses micro-pipette

City centre labs to drive innovation and start-up success

In a move set to propel innovation and growth of early-stage companies, Sheffield Technology Parks (STP) and University of Sheffield are teaming up to build new lab spaces in the city centre.

An image of the Tasty Spoon concept, an arm of a woman is holding the spoon above a plate. The spoon is grey.

New ‘Tasty Spoon’™ will enhance food flavours for people living with dementia

A spoon, designed to enhance the flavour of food for dementia patients experiencing a loss of taste, could help combat high levels of malnutrition.
Group of people talking at an event

Northern universities launch spinout mentor network to empower entrepreneurs

The universities of Sheffield, Leeds, and Manchester are proud to announce the launch of the Northern Triangle Mentor Network, a dynamic initiative designed to propel commercialisation opportunities and empower early-stage spinouts.
Medical illustration of a brain with stroke symptoms

New company Midland Pharmaceuticals launched to develop therapeutics for stroke and spinal cord injury

Researchers from the University of Sheffield and the University of Birmingham have joined forces with NLC Health Ventures to co-found a company developing new treatments for spinal cord injuries and stroke.
DNA Molecule

Sheffield spinout company grows to lead on next generation biomedicines and bioprocesses

SynGenSys, a fast-growing biotechnology company spun out of the University of Sheffield, has announced the appointment of Dr. Andy Racher as its Commercial Operations Director.
A portrait photo of Professor James Marshall

World leading expert on bio-inspired AI to direct University of Sheffield’s Centre for Machine Intelligence

One of the world’s leading innovators in bio-inspired AI has joined the University of Sheffield, as part of a new multi-million pound centre that is set to transform the institution’s research, innovation and teaching around artificial intelligence.

Dr Tim Craggs with instrument

Northern Triangle Talent Project secures £1.5m funding to strengthen regional commercialisation activity

The Northern Triangle Talent Project has secured funding to strengthen the regional technology commercialisation ecosystem and attract top talent to the north of England.
DNA Molecule

University of Sheffield spinout company to pioneer novel therapies for genetic neurological diseases

BlackfinBio has raised £2.75 million seed investment to advance revolutionary treatments for Hereditary Spastic Paraplegia (HSP).

A close up of plastic pellets produced by Floreon

World’s first low-energy bioplastics developed with the University of Sheffield raises £2 million investment

The world’s first low-energy, non-oil-based, high-performance bioplastic, developed by Floreon with the University of Sheffield, has secured £2 million financing from Northern Gritstone.

Neuron cells system - 3d rendered image of Neuron cell network on black background

University of Sheffield spinout company Crucible Therapeutics raises £5 million to advance pioneering treatments for neurological diseases

University of Sheffield spinout company, Crucible Therapeutics, a biotechnology company developing novel therapies to treat the most common genetic form of MND and frontotemporal dementia (FTD), has secured £5 million from Northern Gritstone.
An aerial view of the University of Sheffield Innovation District featuring the Factory 2050 building

Investment zones are the key to taking our potential towards prosperity

Professor Koen Lamberts, President and Vice-Chancellor of the University of Sheffield, discusses how the new South Yorkshire Investment Zone can turn Yorkshire's potential into prosperity.

Inner ear

Unlocking the human inner ear for new therapies to improve hearing loss and deafness

An international team of scientists and surgeon has discovered a secure clinical pathway to the inner ear, which will enable the application of a range of regenerative therapies to restore hearing.

A blue sky above the University's Diamond building

Northern Gritstone secures first close of £215 million ahead of making its first investments

A new investment company founded by the universities of Sheffield, Leeds and Manchester to help boost the commercialisation of university spinouts and start-ups in the north of England has today (20 May 2022) announced a first close of £215 million.
Close up of ear

Rinri Therapeutics raises £10 million to advance stem cell therapy for hearing loss

University of Sheffield spinout company, Rinri Therapeutics, has raised a total of £10 million from investors and the UK Future Fund to advance its novel stem cell therapy to restore hearing loss.

Abstract woman scientist illustration

Sheffield spin-out set up to facilitate life-science discoveries

Understanding how molecules interact within the body is essential in supporting the development of treatments and therapies. Exciting Instruments, a University of Sheffield spin-out company, is breaking down barriers for researchers in this field.
Thumbnail

Northern Gritstone announces leadership team

Northern Gritstone, a new investment company founded by the Universities of Leeds, Manchester and Sheffield, has appointed Lord Jim O’Neill as Non-Executive Chairman and Duncan Johnson as CEO.
Universities of Sheffield, Leeds and Manchester launch Northern Gritstone

Northern universities launch new investment company

The universities of Sheffield, Leeds and Manchester are launching a new investment company to help boost the commercialisation of university spinouts and start-ups in the North of England.